Tranexamic Acid to Reduce Blood Loss in Spine Surgery

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Spinal InjuriesSpinal Deformity
Interventions
DRUG

Tranexamic Acid

"3.0 grams of tranexamic acid will be poured in the surgical field and left in contact for five minutes. Subsequently, excess study solution will be suctioned away without touching the surrounding tissue surfaces and then the would closed without irrigation or manipulation.~TXA solution will be prepared using a dose of 3 grams of tranexamic acid combined with 70 mL of sterile normal saline, for a total volume of 100 mL."

DRUG

Placebo

"Placebo will be poured in the surgical field and left in contact for five minutes. Subsequently, excess solution will be suctioned away without touching the surrounding tissue surfaces and then the would closed without irrigation or manipulation.~The placebo solution will be 100 mL of sterile normal saline."

Trial Locations (4)

10032

RECRUITING

NYP/The Allen Hospital - CUIMC, New York

27710

RECRUITING

Duke University Medical Center, Durham

40202

RECRUITING

Norton Leatherman Spine Center, Louisville

94149

RECRUITING

University of California San Francisco Medical Center, San Francisco

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Columbia University

OTHER